FDA to let women try new breast drugs earlier

Published June 3, 2012

FDA to let women try new breast drugs earlier

Filed under: Baltimore Drug Treatment Centers

By Julie Steenhuysen | CHICAGO (Reuters) – Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try breakthrough drugs while they have the best …
Read more on Reuters

Bristol Immune Drug Success in Cancer May Spur Industry Race

Filed under: Baltimore Drug Treatment Centers

The findings hint that therapies like the Bristol drug, that prompt killer T-cells to eliminate invaders, may work against many tumors, said James Allison, an immunologist at Memorial Sloan-Kettering Cancer Center in New York.
Read more on BusinessWeek

ASCO: MEK Blocker Scores in Mutated Melanoma

Filed under: Baltimore Drug Treatment Centers

The MEK inhibitor significantly cut the odds of both tumor progression and death by more than 50%, Keith T. Flaherty, MD, of Massachusetts General Hospital Cancer Center in Boston, and colleagues found. Progression-free survival (PFS) rose by about 3 …
Read more on MedPage Today